Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MEDVidi vs NP2GO

MEDVidi
Graded #384

Lower grade

vs+22.200000000000003
NP2GO
Graded #37

Higher grade

The verdict

NP2GO takes it — 80.2/100 to 58/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +36
45
81
Dose & formulationNP2GO +27
53
80
Clinical oversightNP2GO +2
77
79
Labs & monitoringNP2GO +16
62
78
FulfillmentNP2GO +23
59
82
Contract termsNP2GO +27
55
82
MEDVidi · left barNP2GO · right bar

The numbers

MetricMEDVidiNP2GO
WeighScore58/10080.2/100
GradeCB−
Scorecard rank#384#37
SemaglutideNot disclosed$150/mo
TirzepatideNot disclosed$250/mo
CoverageCoverage not published40 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard